Radival CR 500 (OSodium Valproate & Valproic Acid Controlled Release (333mg/145mg))

Radival CR-500 combines Sodium Valproate (333 mg) and Valproic Acid (145 mg) in a controlled-release formulation designed for effective management of epilepsy and bipolar disorder. This powerful combination works by increasing gamma-aminobutyric acid (GABA) levels in the brain helping to stabilize mood and prevent seizures. The controlled-release feature ensures consistent delivery of the medication enhancing therapeutic effectiveness and improving patient adherence to treatment regimens.